204 related articles for article (PubMed ID: 8420053)
1. Membranous allograft nephropathy. Remission of nephrotic syndrome with pulsed methylprednisolone and high-dose alternate-day steroids.
Johnston PA; Goode NP; Aparicio SR; Davison AM
Transplantation; 1993 Jan; 55(1):214-6. PubMed ID: 8420053
[No Abstract] [Full Text] [Related]
2. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
Fujimoto S; Yamamoto Y; Wakisaka O; Hisanaga S; Miyata J; Tanaka K
Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
[No Abstract] [Full Text] [Related]
3. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
4. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
Ardiles LG; Mezzano SA
Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
[No Abstract] [Full Text] [Related]
5. The Medical Research Council trial of short-term high-dose alternate day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party.
Cameron JS; Healy MJ; Adu D
Q J Med; 1990 Feb; 74(274):133-56. PubMed ID: 2189149
[TBL] [Abstract][Full Text] [Related]
6. [Membranous nephropathy and crescentic glomerulonephritis].
Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F
Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015
[TBL] [Abstract][Full Text] [Related]
7. Membranous nephropathy associated with acute myeloid leukemia.
Sahiner S; Ayli MD; Yüksel C; Oneç K; Abayli E
Transplant Proc; 2004 Nov; 36(9):2618-9. PubMed ID: 15621104
[TBL] [Abstract][Full Text] [Related]
8. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
Polenakovic M; Grcevska L; Dzikova S
Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
10. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Goumenos DS; Kalliakmani P; Tsakas S; Sotsiou F; Vlachojannis JG
Clin Nephrol; 2004 Jan; 61(1):17-24. PubMed ID: 14964453
[TBL] [Abstract][Full Text] [Related]
11. Membranous nephropathy--still a treatment dilemma.
Cameron JS
N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
[No Abstract] [Full Text] [Related]
12. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
13. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
[TBL] [Abstract][Full Text] [Related]
14. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
[TBL] [Abstract][Full Text] [Related]
15. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.
Jha V; Ganguli A; Saha TK; Kohli HS; Sud K; Gupta KL; Joshi K; Sakhuja V
J Am Soc Nephrol; 2007 Jun; 18(6):1899-904. PubMed ID: 17494881
[TBL] [Abstract][Full Text] [Related]
17. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
[TBL] [Abstract][Full Text] [Related]
18. Two-color analysis of lymphocyte subpopulations in patients with nephrotic syndrome due to membranous nephropathy.
Ozaki T; Tomino Y; Nakayama S; Koide H
Clin Nephrol; 1992 Aug; 38(2):75-80. PubMed ID: 1516283
[TBL] [Abstract][Full Text] [Related]
19. [Quadritherapy with cyclosporine for membranous lupus nephropathy].
Matsumoto H; Okada T; Nagaoka Y; Tomaru R; Iwasawa H; Wada T; Nakao T
Nihon Jinzo Gakkai Shi; 2003 Oct; 45(7):689-94. PubMed ID: 14631764
[TBL] [Abstract][Full Text] [Related]
20. [Idiopathic membranous nephropathy associated with anti-calcineurin toxicity. Prognosis and other immunosuppressive treatments].
Muñoz Díaz AB; Aguilar P
Nefrologia; 2004; 24 Suppl 3():76-80. PubMed ID: 15219075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]